FRTX Description — Fresh Tracks Therapeutics Inc
Fresh Tracks Therapeutics is a clinical-stage pharmaceutical company focused on the development of prescription therapeutics for the treatment of debilitating skin diseases with a focus on its main asset for the treatment of hyperhidrosis. Co.'s investigational product candidate, sofpironium bromide, is a chemical entity that belongs to a class of medications called anticholinergics. Anticholinergics block the action of acetylcholine, a chemical that transmits signals within the nervous system that are responsible for a range of bodily functions, including activation of the sweat glands. Co. is developing sofpironium bromide in the U.S. for the treatment of primary axillary hyperhidrosis.
|
Free FRTX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|